1. Home
  2. FGBI vs EQ Comparison

FGBI vs EQ Comparison

Compare FGBI & EQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Guaranty Bancshares Inc.

FGBI

First Guaranty Bancshares Inc.

HOLD

Current Price

$8.71

Market Cap

134.1M

Sector

Finance

ML Signal

HOLD

Logo Equillium Inc.

EQ

Equillium Inc.

HOLD

Current Price

$1.88

Market Cap

140.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FGBI
EQ
Founded
1934
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
134.1M
140.1M
IPO Year
2014
2018

Fundamental Metrics

Financial Performance
Metric
FGBI
EQ
Price
$8.71
$1.88
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$8.00
AVG Volume (30 Days)
14.0K
404.3K
Earning Date
04-27-2026
05-25-2026
Dividend Yield
0.44%
N/A
EPS Growth
N/A
N/A
EPS
0.31
N/A
Revenue
N/A
$41,095,000.00
Revenue This Year
$567.70
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$27.39
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.31
$0.76
52 Week High
$11.02
$3.54

Technical Indicators

Market Signals
Indicator
FGBI
EQ
Relative Strength Index (RSI) 50.74 37.91
Support Level $8.24 $1.68
Resistance Level $8.86 $1.97
Average True Range (ATR) 0.29 0.17
MACD 0.08 -0.04
Stochastic Oscillator 72.64 10.11

Price Performance

Historical Comparison
FGBI
EQ

About FGBI First Guaranty Bancshares Inc.

First Guaranty Bancshares Inc provides personalized commercial banking services to its customers in Louisiana through several banking facilities. The company offers commercial real estate loans, commercial and industrial loans, construction and land development loans, agricultural and farmland loans, and, to a lesser extent, consumer and multifamily loans. The company is engaged in a single line of business as a financial institution, which provides a full range of banking, financial, and trust services to state, county, and local government entities, individuals, and small and commercial businesses.

About EQ Equillium Inc.

Equillium Inc is a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders with the mission to develop life-changing therapeutics for patients. It primary goal is to advance EQ504, a novel aryl hydrocarbon receptor, or AhR, modulator, into and through clinical development. The Company operates through a single operating and reportable segment focused on the business of developing novel therapies to treat severe autoimmune and inflammatory disorders, with the mission to develop life-changing therapeutics for patients. The Company manages all business activities on a consolidated basis.

Share on Social Networks: